Holen Sie sich die Stockscreener-App
80.26
1.23%
-1.06
Handel nachbörslich:
80.50
0.24
+0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$81.32
Offen:
$80.78
24-Stunden-Volumen:
4.86M
Relative Volume:
0.90
Marktkapitalisierung:
$33.64B
Einnahmen:
$9.51B
Nettoeinkommen (Verlust:
$2.64B
KGV:
13.30
EPS:
6.0361
Netto-Cashflow:
$2.14B
1W Leistung:
+1.77%
1M Leistung:
-31.27%
6M Leistung:
-37.10%
1J Leistung:
-50.60%
1-Tages-Spanne:
$79.94
$81.31
1-Wochen-Bereich:
$76.21
$82.34
52-Wochen-Spanne:
$72.38
$172.23
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
80.24 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.63 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
Zoetis Inc. (ZTS) Stock Analysis: Exploring a 53% Potential Upside in the Animal Health Leader - DirectorsTalk Interviews
Zoetis Stock Rockets 9.6% With 5-Day Winning Streak - Trefis
Zoetis elects directors and reports shareholder votes at annual meeting By Investing.com - Investing.com Nigeria
Zoetis Stock 5-Day Winning Spree: Stock Climbs 9.6% - Trefis
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Zoetis, Inc. (ZTS) Investors to Inquire about Securities Investigation - The National Law Review
Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Norfolk Daily News
Zoetis Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Zoetis Inc. Files Form 8-K Reporting Annual Meeting Results and Shareholder Votes – May 2026 - Minichart
Stifel cuts Zoetis stock price target on competitive pressures By Investing.com - Investing.com South Africa
Stifel Maintains Zoetis(ZTS.US) With Hold Rating, Cuts Target Price to $95 - Moomoo
Stifel cuts Zoetis stock price target on competitive pressures - Investing.com
Zoetis elects directors and reports shareholder votes at annual meeting - Investing.com
Zoetis Faces Fraud Probe As Burry Backs Dividend-Paying Animal Health Firm - Sahm
Declaration of Voting Results by Zoetis Inc - marketscreener.com
Zoetis faces securities fraud probe after Q1 profit guidance cut and 21.5% stock drop - Pluang
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zoetis, Inc. (ZTS) And Encourages Investors to Reach Out - ACCESS Newswire
What's Driving Zoetis's Recent Volatility and Dividend Appeal - Kavout
Return on invested capital % of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc.ZTS - PR Newswire
Total liabilities & shareholders' equities of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
Zoetis, Inc. Class A Cash Flow – BVL:ZTSUS - TradingView
Zoetis, Inc. Class A Balance Sheet – BVL:ZTSUS - TradingView
Asset turnover of Zoetis, Inc. Class A – BVL:ZTSUS - TradingView
Zoetis Inc. (ZTS) to Attend Investor Conferences Amidst Challenging Market Conditions - GuruFocus
Zoetis Probe Tests Guidance Credibility And Long Term Investor Confidence - Yahoo Finance
Zoetis shares plunge 21.5% after cutting 2026 revenue forecast amid weak pet-care demand. - Pluang
Can Zoetis Face NYSE Composite Pressure After Guidance Review? - Kalkine Media
Levi & Korsinsky Announces Investigation of Securities Claims Against Zoetis (ZTS) - GlobeNewswire
Zoetis to Participate in Upcoming Investor Conferences - The Joplin Globe
Veterinary Healthcare Market to Witness Massive Growth by 2033 | Zoetis Inc., Virbac SA, Vetoquinol SA - EIN News
Zoetis (ZTS) Declares Quarterly Dividend Amid Revised Revenue Ou - GuruFocus
Zoetis Inc. (ZTS) Announces Third Quarter Dividend for 2026 - GuruFocus
Insiders and Institutions Snap Up Zoetis Shares at Steep Discount as US Pet Sales Slump - AD HOC NEWS
Zoetis Declares Third-Quarter 2026 Cash Dividend - TipRanks
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Zoetis Inc. stock rises Wednesday, still underperforms market - MarketWatch
Zoetis Keeps Quarterly Dividend at $0.53 per Share, Payable Sept. 1 to Holders of Record July 20 - marketscreener.com
Zoetis declares $0.53 quarterly dividend payable Sept. 1, record date July 20 - TradingView
Zoetis declares $0.53 quarterly dividend, payable Sept. 1 By Investing.com - Investing.com Canada
Zoetis declares $0.53 quarterly dividend, payable Sept. 1 - Investing.com
Zoetis (ZTS) Board approves $0.53 per-share dividend for Q3 2026 - Stock Titan
Zoetis Declares Third Quarter 2026 Dividend - The Joplin Globe
Zoetis Q1 earnings lag estimates, 2026 view cut, stock down - MSN
ZTS Investor Alert: Levi & Korsinsky Investigates Zoetis (ZTS) for Potential Securities Fraud - Morningstar
Zoetis Stock Pulls Back to Support – Smart Entry? - Trefis
Barclays (DJP) prices Zoetis‑linked Notes with 13.20% digital payout - Stock Titan
Zoetis Stock Near Crucial SupportBuy Signal? - Trefis
ZTS News | ZOETIS INC (NYSE:ZTS) - ChartMill
Zoetis Inc. announces Quarterly dividend, payable on September 01, 2026 - marketscreener.com
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.03%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):